Srinivas Akkaraju, Director at ZS Pharma, holds 6.35M shares in Alumis Inc. (Ticker: ALMS), holds 12.95M shares in Kalaris Therapeutics (Ticker: KLRS), holds 6.92M shares in Scholar Rock Holding (Ticker: SRRK). Most recently, Srinivas Akkaraju Bought ― shares of Alumis Inc. on Jan 13, 2026 for an estimated value of $10.00M.
Srinivas Akkaraju latest transaction was an Informative Buy of $10.00M.
What was Srinivas Akkaraju's most profitable transaction?
Srinivas Akkaraju’s most profitable transaction was an Informative Buy of ALMS stock on May 6, 2025. The return on the trade was 317.90%.
What is Srinivas Akkaraju's role in ZS Pharma?
Srinivas Akkaraju's role in ZS Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.